Acute chest pain, a common yet perplexing clinical presentation, often poses diagnostic challenges for healthcare professionals. The differential diagnosis is broad, ranging from benign musculoskeletal causes to life-threatening conditions such as myocardial infarction. This article provides a comprehensive approach to evaluating and managing patients presenting with acute chest pain.
Initial evaluation should involve a detailed history and physical examination. Key elements include the character, onset, location, duration, associated symptoms, and any exacerbating or relieving factors. Concurrently, vital signs and electrocardiogram (ECG) should be obtained promptly to identify any immediate life-threatening conditions.
Further diagnostic evaluation depends on the initial clinical assessment. For patients with suspected cardiac chest pain, serial cardiac biomarkers and a stress test may be indicated. In cases of suspected pulmonary embolism or aortic dissection, computed tomography angiography (CTA) may be required. For patients with a low pretest probability of cardiac etiology, alternative diagnoses such as gastroesophageal reflux disease or musculoskeletal pain should be considered.
Management depends on the underlying cause of chest pain. Patients with acute coronary syndrome require prompt revascularization, while those with pulmonary embolism may require anticoagulation. It is also essential to address modifiable risk factors and provide appropriate counseling to patients.
Acute chest pain is a complex clinical entity that requires a systematic approach for effective evaluation and management. By tailoring the diagnostic workup based on initial assessment and considering a broad differential diagnosis, healthcare professionals can ensure optimal patient outcomes. Continued education and clinical vigilance are key in this constantly evolving field.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation